This study include, the partial purification of L-glutaminase enzyme from E.coli by ammonium sulphate precipitation (40%-80%) fractions, and the enzyme activity elevated to 75 IU/ml following dialysis. Pharmacological evaluation of L-glutaminase enzyme was used for the in vivo studies on sixty rats as an animal models. The hematological parameters for rats in the treated group (T2) showed significant changes at the level (P<0.05) when compared with normal control group (T1). The WBCs was found to be increased with the reduction in the RBCs and Hemoglobin (Hb.) concentration. However there were no significant changes of these parameters in the other treated groups (T3, T4, T5, and T6) in contrast to (T1). The serum total protein, globulin and, albumin were found to be decreased significantly for the (T2) in comparison with the (T1). However, their level had been relatively normalized in comparison to (T2) as a result of administrating doses of 0.5, and 1.0 ml L-glutaminase in combination with 0.5 mg ethylenimine /Kg. body weight for T5 and T6 respectively. Concerning the level of serum globulins, there were a significant elevation in the serum globulins value for T5 and T6 which were treated with doses of 0.5 and 1.0 ml L-glutaminase in combination with 0.5 mg ethylenimine/Kg. body weight respectively. While, a significant decrease in the values of serum albumin detected in all rats' treated groups and the L-glutaminase efficacy was not achieved completely compared with the T1.The Liver enzymes ALT, AST and, ALP for T2 showed significant elevation at the level (p<0.05) when compared with T1. The treatment with L-glutaminase at doses of 0.5 and, 1 ml /kg body weight in combination with 0.5 mg of ethylenimine/kg body weight in T5 and, T6 groups respectively, seem to reverse the changes to word near normal level. There were a 
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Introduction:
Enzymes are selective catalytic proteins which produced by living cells and may or may not contain prosthetic group [1] . L-glutaminase (L-glutamine amidohydrolase EC 3.5.1.2) catalysis the hydrolysis of L-glutamine to glutamic acid and ammonia [2] . The L-glutaminase enzyme plays a major role in the cellular nitrogen metabolism of both prokaryotes and eukaryotes, and can be derived from plant, animal tissues and microorganisms including bacteria, yeast and fungi [3] . The L-glutaminase produced by various microorganisms but the enzyme with the best properties have been purified from the family of enterobacteriaceae especially from E.coli [4] .
The E.coli attracts the attention of many investigators, and they studied its ability for the production of such enzyme [4 9 -] . The advantage of using microorganisms for the production of L-glutaminase is the economical bulk production capacity, and also the microbes are easy to manipulate to obtain enzymes of desired characteristics [3] .
Over a few decades, L-glutaminase attracted more attention in both food industrial and pharmaceutical applications. It used as enzyme therapy for cancer especially for acute lymphocytic leukemia [10] , it also used in biosensors for monitoring the glutamine levels in mammalian and hypridoma cells. However in 1993, Pseudomonas species recombinant glutaminase was patented for its activity against cancer, and HIV virus therapy [11] . Hence the aim of the present study is to evaluate the therapeutic capacity of L-glutaminase enzyme for preventing the mutagenic, and carcinogenic effect of ethylinmine in vivo using rat groups as an animal model. 72 hours at 4°C and the buffer were changed occasionally [13] . Finally, L-glutaminase activity of dialysate was assayed according Imada, et.al [14] .
Materials and
In vivo testing therapeutic characteristic of L-glutaminase:
Laboratory Animals Initialization:
Sixty male rats had 200-250g weight, 4 weeks-old (Albino-Sprague Dawley Rats) were individually weigheted, wing banded and housed in heated battery brooders under 12 hrs.
Fluorescent lighting daily, with feed and water provided ad libitum. Rats were fed the optimal formula according to [15] . The experimental design consisted of six dietary treatments by the intravenous injection from partially purified L-glutaminase enzyme with 75 IU/ml activity. The
Rats were administrated Ethylenimine 0.5 mg (dissolved in d.w)/kg. body weight each 72 hrs., for four weeks in the treated group (T2). The rats were randomly assigned to the following treated groups Table 1 . There were two replicates of five rats per dietary treatment and the rats were maintained on these treatments for 15 weeks period. 
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Gt + E 1ml+0.5 mg/kg. of Body weight CD CD+Gt+E CD+Gt E =Ethylenimine; CD = control diet; Gt = L-glutaminase.
Parameters Studies:
Haematological parameters:
Following 15 weeks of treating rats with L-glutaminase, and Ethylenemine, and following deep ether anesthesia, the ventral side of treated rats were cutted, then five milliliters of blood were collected from posterior vena cava, dispensed in two tubes, one of them without EDTA for biochemical tests, and the other with EDTA for hematological parameters determination according to (16) . All blood samples were labeled and immediately analysis. For measuring Ethylenimine which might stimulate the host immune system, and suppress the erythropoisis or increase the hemolysis above the normal rate. However its effect was dose dependent. 
Effect of Ethylenimine and L-glutaminase on The Hematological Parameters:
Effect of Ethylenimine and L-glutaminase on Serum Proteins:
The interaction effects of the intravenous injection of L-glutaminase and the oral administration of Ethylenimine on biochemical parameters of rat groups were investigated.
According to the results illustrated in Table 3 , the serum total protein, globulin and, albumin were found to be decreased significantly (p<0.05) for the treaded group (T2) which became 5.34, 3.04, and 2.30mg/dl respectively compared with the control group(T1) which were 6.82, 4.21 of pulmonary adenomas and hepatomas in male and female B6C3F1 mice and B6AKF1 males [18] . So it affect on the level of proteins made by liver including albumin, which is the main component of total proteins [19] . The remaining fraction is called globulin (including the immunoglobulin's). Albumin levels are decreased in liver disease [20] . The hypoalbuminemia may also occur in protein malnutrition, nephritic syndrome, chronic protein losing enteropathies [21] , as well as acute, and chronic inflammatory disorders, in addition to most cases in hepatocellular diseases result from different causes as increased immunoglobulin concentrations, and direct inhibition of synthesis by toxins and alcohol [22] . High serum globulin levels may be indicative of some chronic inflammatory, infectious disease, an autoimmune disease such as lupus, rheumatoid arthritis, liver disease, kidney disease, or carcinoid tumors, leukemia, or other bone marrow disease [23] . 
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T1: control group; T2: 0.5mg Ethylenimine/kg; T3: Glutaminase 0.5ml/kg; T4: Glutaminase 1ml/kg; T5: 0.5ml/kg Glutaminase+0.5mg Ethylenimine/kg; T6: 1ml/kg Glutaminase+0.5mg
ethylenimine/kg. a, e: Values within columns followed by different letters differ significantly at (p<0.05).
Effect of Ethylenimine and L-glutaminase on Serum Enzymes:
As shown in Table 4 , the liver enzymes of rats in the treated group (T2) which were group. These results were demonstrated that L-glutaminase improve the levels of the serum muscles [26] . Alkaline phosphatase (ALP) is other liver enzyme. the elevation of ALP is indicate the damage of hepatic cells. Since this enzyme exists in cytoplasm, and it releases to circulation after liver damage [27] , also the development of tumor causes tissue damage and leads to increase ALP level [28] . 
Effect of Ethylenimine and L-glutaminase on Relative Organ Weights:
The relative weight of Liver, kidney and spleen organs of the experimental animal had been weighted following treatment period as presented in Table 5 . There were a significant elevation in the relative weight of above organs of rats in treated group (T2) that administrated 1mg ethylenimine /Kg body weight and became 7.69, 5.74 and 2.83 respectively in comparison with control group (T1) which were 4.35, 3.86 and 1.65 respectively. There were no significant changes in the weight of above organs of rats in the T3 and T4 groups which received 0.5 and 1 ml intravenous doses of L-glutaminase. However, their weight decreased significantly in T5 group as a result of administering 0.5ml L-glutaminase in relation with 0.5 mg ethylenimine/kg body weight and became 5.72, 4.90 and 2.14 respectively in comparison to treated group (T2), but still high significantly when compared with control group (T1). Whereas the organs' relative weight were 4.47, 3.98 and 1.78 respectively for the T6 group, and there were no significant differences from that of control group. These observations explained the importance of Lglutaminase in preserving the organs from damage by toxic effect of Ethylenimine. Furthermore, The potential carcinogenicity of ethylenimine was evaluated by International Agency for
Research on Cancer IARC [29] and concluded that ethylenimine is possibly carcinogenic to humans. Because ethylenimine is a direct-acting alkylating agent that is mutagenic in a large number of test systems, including bacteria, insects, mammalian cells in culture, and mice (assessed in vivo by the dominant lethality test). The finding of the present study improved the preventive role of the L-glutaminase against the mutagenic effect of ethylinimine, and it was dose dependent. Pandian, et.al. [30] reported that purified L-glutaminase from Alkaligene faecalis 
